Pregnancy Complications Flashcards
Pregestational HIV Infection
- 90% of pediatric HIV infection d/t vertical transmission
-
Treatment in pregnancy
- Treat prenatally, in labor, newborn
-
HAART (Highly active antiretroviral therapy)
- Goal HIV viral load < 1,000
- Attempt vaginal delivery if < 1,000
- Elective C-section of > 1,000
- Goal HIV viral load < 1,000
-
HAART (Highly active antiretroviral therapy)
- If no prenatal care prior to onset of labor ⇒ ✓ rapid HIV test
- Treat prenatally, in labor, newborn
-
Minimize invasive procedures
- Artificial rupture of membranes
- Operative vaginal delivery
- Fetal scalp electrodes
- Postpartum – No breastfeeding

Pregestational Asthma
Characteristics
- One of the most common medical conditions in pregnancy
-
Management complicated by:
-
Effect of pregnancy on asthma is variable
- Elevation of diaphragm by gravid uterus ⇒ ↓ FRC but ↔︎ peak expiratory flow rate and FEV1
- Potential effect of meds used to tx
- Adverse effects of asthma on fetus and pregnancy progression
-
Effect of pregnancy on asthma is variable
-
Important to monitor severity of disease:
- Maternal sx: wheezing, SOB
- Track FEV1 (nl 380-550 L/min in pregnancy)

Pregestational Asthma
Management
Goal to prevent acute exacerbations and optimize pulmonary function.
Treatment is the same as w/o pregnancy except avoid systemic steroids.

Pregestational Thyroid Disease
Overview
- 2nd most common endocrine disease in pregnancy
-
Thyroid function changes in pregnancy:
-
↑ Thyroxine binding globulin d/t estrogen
- ↑ total T3 and T4 but not free hormone levels
-
hCG ⇒ ⊕ TSH receptor
- ↑ free T3/T4 & ↓ TSH
- Effect is transient during peak hCG levels (10-12 wks)
-
↑ Thyroxine binding globulin d/t estrogen
-
T4 important in fetal brain development until 18-20 wks (then fetal thyroid takes over)
- Must dx and tx hypothyroidism in early pregnancy
-
Thyroid function testing: use TSH and free T4 levels
- Hx of thyroid disease
- Sx of hypo/hyperthyroidism
Pregestational Hypothyroid
-
Most common etiologies:
- Hashimoto’s thyroiditis
- Post-ablative therapy
-
Diagnosis:
- Overt: ↑ TSH and ↓ free T4
- Subclinical: ↑ TSH and nl free T4
-
Treatment:
-
Levothyroxine
- Pregnancy ↑ dose requirements
- Check TFTs every 4 wks while adjusting
- Check every trimester when stable
-
Levothyroxine
-
Complications:
- Neuropsychological impairment of fetus
- Preeclampsia
- Placental abruption
- Preterm delivery
- Postpartum hemorrhage
Pregestational Hyperthyroid
- Occurs in 0.2% of pregnancies
- Grave’s disease in 90% of cases
-
Diagnosis:
- ↓ TSH and ↑ free T4
-
Treatment:
-
Primarily medical: PTU and Methimazole
- Both cross placenta and can cause fetal hypothyroidism
-
1st trimester: PTU
- Risk of maternal liver toxicity w/ PTU
- Safer for baby
- Methimazole is a teratogen
- 2nd / 3rd trimester: Methimazole
- Safer for mom
- Lowest dose to maintain free T4 in high nl range
-
Thyroidectomy in refractory cases
- Ablation contraindicated in pregnancy
-
Primarily medical: PTU and Methimazole
-
Complications:
- Miscarriage
- Preterm labor
- Low birth weight
- IUFD
- Preeclampsia
- Heart failure
-
Thyroid Storm
- Life threatening
- N/V, fever, tachycardia, delirium
- Treat in ICU, high dose PTU, steroids, propranolol
Venous Thromboembolism
Overview
- DVT and PE
- Rate 4-50x higher in pregnant vs non-pregnant women
-
Higher incidence:
- Postpartum
- Cesarean section
- Pregnancy promotes all the components of Virchow’s Triad
- Inherited thrombophilia ⇒ significantly ↑ risk VTE
-
Diagnosis:
- Difficult as signs/sx mimic nl pregnancy
- Low extremity swelling
- Dyspnea
- Labs:
- ABG: low sensitivity and specificity
- D-dimer: high sensitivity but low specificity
- Imaging:
- Lower extremity Doppler U/S (DVT)
- MRI (DVT)
- V/Q scan (PE)
- CT angio (PE)
- Difficult as signs/sx mimic nl pregnancy

Venous Thromboembolism
Treatment & Prophylaxis
-
Treatment:
-
Anticoagulation
- Unfractionated heparin
- LMW heparin (Lovenox)
- Coumadin post-partum only
- Teratogenic
-
Duration of therapy
-
At least 6 months after dx and 6 wks postpartum
- Can be transitioned to Coumadin postpartum
-
At least 6 months after dx and 6 wks postpartum
-
Anticoagulation
-
Prophylaxis:
-
Women at high risk
- Hx of VTE
- Cardiac valves
- Thrombophilia
- Morbid obesity
- Prolonged immobility
-
Therapy
- Depending on indication: duration of pregnancy and postpartum
- Heparin or LMW Heparin, prophylactic doses
-
Women at high risk
Pregestational Seizure Disorder
Overview
- Most frequent neurologic complication of pregnancy
-
Pregnancy may ↑ seizure frequency
-
↓ Levels of antiepileptic drugs (AEDs)
- ∆ Clearance, protein binding, volume of distribution
- ↓ Compliance
- Sleep deprivation
-
↓ Levels of antiepileptic drugs (AEDs)
-
Concerns:
-
↑ Risk of malformations w/ all AEDs
- Depakene (valproic acid) ⇒ neural tube defects
- Dilantin (phenytoin) ⇒ hydantoin syndrome
- ? ↑ Rate of fetal growth restriction and stillbirth
-
↑ Risk of malformations w/ all AEDs
Pregestational Seizure Disorder
Management
-
Consultation w/ neurologist
- Are meds needed?
-
AED: lowest dose, newer meds, monotherapy
- Avoid valproate if possible
- Monitor drug levels
- Folic acid supplementation 4 mg/day
-
Malformation screening
- Ultrasound
- Maternal serum AFP
Trauma During Pregnancy
-
Penetrating trauma
- More likely to injure fetus than maternal abd structures
-
Blunt trauma
- Non-viable fetus (< 24 wks)
- Assess maternal blood type and administer Rhogam
- Viable fetus (> 24 wks)
- Monitor for evidence of abruption
- Non-viable fetus (< 24 wks)
Appendicitis During Pregnancy
- Most common surgical condition in pregnancy
- Location of the appendix can be altered in pregnancy
- Imaging: attempt US first, but CT scan as needed
- Outcomes worse if perforation occurs
- Surgical approach depends on gestation (laparoscopy vs. open)
Hyperemesis Gravidarum
-
Severe nausea and vomiting of pregnancy with:
- Electrolyte abnormalities (hypokalemia)
- Starvation ketosis
- Weight loss from pre-pregnancy (> 5%)
- Mostly during 1st trimester
- Affects 2% of pregnancies
- Unclear etiology (possible related to elevated hCG levels)
-
Differential Dx: anything that causes N/V
- Pancreatitis, appendicitis, DM, migraines, drug intoxication
- Rarely results in severe adverse maternal or fetal effects
-
Management:
- Hospitalization
- Antiemetics, vitamin B6
- IVF until able to tolerate meals
- If persistent weight loss ⇒ PICC line and TPN
Intrahepatic Cholestasis of Pregnancy
- Elevated serum bile acid concentration and severe itching (palms and soles)
- 2nd and 3rd trimester
- Variable incidence (1-15%)
- Higher in Latin ethnic groups
- Genetic link, but thought to be related to estrogen effect on bile acids
- Differential Dx: other liver or biliary diseases
- No adverse maternal effects
- ↑ risk of fetal death and respiratory distress syndrome
-
Management:
- Actigall (ursodiol): improves bile flow
- Benadryl for pruritus
- Fetal testing w/ delivery between 36-38 wks
Gestational Thrombocytopenia
-
Low platelet count during pregnancy
- Mild > 70k, most are >120k
- Women are asymptomatic
- No hx of platelet abnormality predating pregnancy
- Returns to nl postpartum
- Occurs in 3rd trimester
- Roughly 5% of pregnancies
- Unclear etiology
- Anti-platelet antibodies present similar to ITP
- Accelerated platelet consumption
- DDx: ITP, TTP, Preeclampsia/HELLP syndrome
- No significant fetal or maternal effects
- Some anesthesiologists will not place epidural w/ low platelets
- No specific management
Pruritic Urticarial Papules and Plaques of Pregnancy (PUPPs)
-
Erythematous and itchy papules and plaques that develop striated areas
- Mostly on abd, less on thighs
- Not on palms and soles ⇒ diff. from IHCP
- 3rd trimester and postpartum
-
Etiology:
- Stretching of skin causes inflammatory response
- Fetal DNA found in some lesions
- DDx: bed bugs bites, IHCP, Eczema
- Rash and itching can be uncomfortable but no severe fetal or maternal effects
- Management: symptomatic treatment
- Topical corticosteroids
- Oral antihistamines
- Systemic steroids if severe

Hypertension in Pregnancy
- Chronic HTN
- Gestational HTN
- PreEclampsia and Eclampsia
- Chronic HTN w/ superimposed PreEclampsia
Chronic Hypertension (CHTN)
Characteristics
↑ Risk of fetal death, growth restriction, placental abruption, and developing a hypertensive disorder of pregnancy
-
Diagnosis
- BP > 130/80, prior to 20th week of pregnancy, 2 separate occasions
- Known dx of chronic HTN prior to pregnancy
-
Initial Evaluation
- Hx of age of onset, duration, and severity of disease
- May need more extensive work up depending on above
-
Labs/Studies
- EKG, echocardiogram, ophthalmologic exam
- BMP: electrolytes, particularly kidney function
- 24-hour urine collection (protein)
- CBC, LFTs, ± Uric acid
-
Antenatal Testing
- Baseline US at 18-20 wks (anatomy)
- Repeat US every 4 wks starting at 28 wks (growth)
- Non-stress test and/or Biophysical Profile weekly starting at 32 wks
Chronic Hypertension (CHTN)
Management
-
Mild to moderate HTN (140-159/90-109)
- No proven benefit to prevent progression to preeclampsia, growth restriction, neonatal death, or preterm birth
- Therapy instituted for BP > 150/90
-
Severe HTN (> 160/110)
- Prevention of ICH, hypertensive encephalopathy, and ↓ risk of maternal death
Gestational Hypertension
- Systolic BP > 140 or Diastolic BP > 90 on 2 occasions 6 hours apart
- After 20 wks of gestation
- No other signs or sx
- Deliver for OB indications only
Antihypertensives in Pregnancy
-
Acute management
- Recommended for any BP > 170/100
- Labetalol 20-40mg IV q10min
- Hydralizine 5-10mg IV q20min
- Procardia 10-20 mg IV q20-30min
- Sodium Nitroprusside
-
Tritate BPs to no lower than 140/90
- Sign. ↓ BP to “normal” ⇒ ↓ fetal blood flow & uteroplacental insufficiency
- Applies to chronic HTN and HTN disorders of pregnancy
- Recommended for any BP > 170/100
-
Chronic management
- Nifedipine
- Labetalol
- Methyldopa

Diabetes and Pregnancy
- Pregestational vs gestational
-
Hormones of pregnancy ⇒ ↑ insulin resistance as pregnancy progresses
- Progesterone, HPL, Prolactin
- 40% ↑ prevalence of Type II DM
- 90% of diabetes in pregnancy is gestational
Pregestational Diabetes
- Evaluate for hx of DM or undiagnosed pre-existing DM
-
If hx of pre-existing, assess for end-organ damage @ initial prenatal visit
- Retinopathy: ophthalmologic exam
- Cardiovascular: EKG ± ECHO
- Renal: creatinine and 24 hr urine collection to assess proteinuria
- ✓ HgbA1c
- If no hx of DM, screen for gestational or consider testing for type II
-
Important to classify type of DM
- Further along continuum ⇒ ↑ risk of maternal and fetal complications
Gestational Diabetes
-
Risk factors:
- Age (older)
- Race (AA, Latina, Asian)
- Obesity (BMI > 25)
- Family hx (1st deg relative w/ DM)
- Prior GDM or prior adverse OB outcomes suggestive of prior GDM
-
Diagnosis
-
Screening: 1 hr glucose challenge test
- 50-gram glucose load, check BS at one hour
- > 135 considered elevated and need further testing
- Performed b/t 24-38 wks gestational age
-
Diagnostic: 3 hr glucose tolerance test
- 100-gram glucose load, check FBS, one hour, two hr, and three hr BS
- Abnl values are greater than: 90/180/155/140
- At least two abnl values qualifies for diagnosis of GDM
-
Screening: 1 hr glucose challenge test
-
Classifications of DM
- A1/A2: gestational
- B/C/D/F/R/H: pregestational
Diabetes
Pregnancy Complications
-
Maternal
- Diabetic complications may worsen:
- Retinopathy
- Renal, cardiac disease
- ↑ Incidence of DKA
- Spontaneous abortion
- Preeclampsia
- Diabetic complications may worsen:
-
Fetal
-
Congenital anomalies
- Cardiac, CNS
- IUFD (stillbirth)
-
Macrosomia and birth injury
- Big babies indicative of GDM
-
Growth restriction
- Small babies indicative of pre-gestational DM
-
Neonatal cardiomyopathy
- Mostly hypertropic
- Respiratory distress syndrome
- Neonatal hypoglycemia
- ↑ Risk of childhood obesity
-
Congenital anomalies

Classifications of Diabetes in Pregnancy

Diabetes in Pregnancy
Management
-
DM treatment
Achieving glycemic control is the most important factor-
Diet and exercise (A1)
- BS goal: fasting < 95, 2 hrs PP < 120
- Measure BS 4 times daily
-
If BGL remains elevated ⇒ initiate medication therapy
- Glyburide or metformin (PO)
-
Insulin (IV)
- Many regimens available
- Insulin requirements ↑ through pregnancy
- ⅔ and ⅓ rule: ⅔ in the AM, ⅓ in the PM
-
Diet and exercise (A1)
-
Imaging: many ultrasounds
-
1st trimester
- Early to date and assess viability (high miscarriage rate)
-
2nd trimester
- Level II US to assess for fetal anomalies @ 18-20 wks
- Fetal ECHO @ 22 wks
-
3rd trimester
- Growth scans every 4 wks until delivery
-
1st trimester
-
Antenatal testing
- NST/AFI or BPP twice weekly
-
Timing and mode of delivery
- Glycemic control
- Fetal size
- Amniocentesis
-
Postpartum testing
- Screen at 6 wks to assess for non-gestational DM
- ↑ Maternal risk of developing DM later in life
Implantation and Early Development

Placenta and Membranes
Development

Spontaneous Abortion
Overview
- ~10-15% of recognized pregnancies end in spontaneous abortion
- Many more pregnancies end before mother aware she is pregnant
- Mechanisms leading to early loss of pregnancy unclear
-
Fetal factors
-
Genetic or acquired anomaly ⇒ defective implantation
- Can’t support fetal development
- > 50% of spontaneous abortions show chromosomal abnormalities
-
Genetic or acquired anomaly ⇒ defective implantation
-
Maternal factors
-
Inflammatory diseases, both localized to the placenta and systemic
- Includes infections such as Toxoplasma, Mycoplasma, Listeria
- Uterine abnormalities
- Trauma (very rare cause of spontaneous abortion)
-
Inflammatory diseases, both localized to the placenta and systemic
Spontaneous Abortion
Morphology
-
Tissue from spontaneous abortion shows:
- Focal areas of decidual necrosis
- Intense neutrophilic infiltration
- Thrombi within decidual blood vessels
- Old and recent hemorrhage
-
If a fetus is seen, can examine it and look for anomalies
-
Do chromosomal studies if:
- Pt has had > 1 early spontaneous loss
- Fetus is malformed
-
Do chromosomal studies if:
Preterm Delivery
- Delivery prior to 37 completed wks of gestation
- 12% of births in the US
-
Consequences:
- Death
- Respiratory distress syndrome
- Intraventricular hemorrhage
- Necrotizing enterocolitis
- Cerebral palsy
- Visual and hearing impairment
Preterm Labor
- Uterine contractions causing dilation of the cervix
- Unclear etiology
-
Management
- Tocolysis: stop contractions
- Steroids: fetal lung maturity, minimize risks of PTD
- Magnesium sulfate: neuroprotection, ↓ risk of CP
-
Prevention
-
17 alpha hydroxyprogesterone acetate (IM injection)
- ↓ Risk of recurrent preterm birth
-
17 alpha hydroxyprogesterone acetate (IM injection)
Preterm Premature Rupture
- Rupture of amniotic sac prior to labor in a preterm gestation
- Etiology is unclear
-
Management
- Abx: prolongs the latency to delivery
- Steroids: fetal lung maturity, minimize risks of PTD
- Magnesium sulfate: neuroprotection, ↓ risk of CP
-
Prevention:
- 17 alpha hydroxyprogesterone acetate
Disorders of Late Pregnancy
Pregnancy loss in 3rd trimester prompts a search for evidence of the following:
-
Interruption of blood flow through the umbilical cord
- Ex. constricting knots or compression
- Ascending infections involving chorioamnionic membranes
- Retroplacental hemorrhage @ interface of placenta and myometrium (abruptio placentae)
- Rupture of the fetal vessels in terminal villi (intervillous hemorrhage)
-
Uteroplacental insufficiency
- Precipitated by abnormal placentation, altered placental development, or maternal vascular thrombosis
Cervical Insufficiency
Structural weakness of the cervical tissue that leads to pregnancy loss
- Asymptomatic: cervix opens without feeling contractions
- Recurrent
- Occurs during 2nd trimester
-
Congenital vs acquired
- D&E, LEEP, ablation procedures on cervix
-
If hx in a prior pregnancy:
- Follow w/ US (cervical length)
- Cervical cerclage

Placental
Gross Examination
- Needs to be done on all placentas (triage)
-
Required observations:
- Complete or fragmented
- Weight (after removal of cord and membranes)
- Shape
- Discoid/normal
- Multilobate
- Accessory lobes
- % of maternal surface covered by retroplacental hematoma

Placental Architecture
Abnormalities
- Missing cotyledons from maternal surface
- Poor vascularization of fetal surface
-
Abnormal placental shape and peripheral cord insertion
- Marginal
- Velamentous
- Hemorrhage or stricture at cord insertion site
- Vessel number
- Cord accident (true knots)

Umbilical Cord
Abnormalities
- Length
- Local abnormalities
- Nearest distance to margin of placenta
- Vessel number
- Knots (true versus false)
- Embryonic remnants
- Thrombosis

Membrane Abnormalities
-
Meconium staining
- Caused by in utero passing of meconium
- Gross discoloration
- Vacuolation of amniotic epithelium, cell degeneration, epithelial necrosis w/ finely granular brown pigment in MΦ of amnion, chorion and decidua
- Squamous metaplasia
-
Amnion nodusum
- See aggregates of squames and hair
- Related to oligohydramnios
-
Early amnion rupture sequence (bands)
- Example of disruption of normal development

Placenta Accreta
Partial or complete absence of endometrial decidua w/ adherence of placenta directly to myometrium.
- Abnormally adherent to uterus ⇒ fails to separate following delivery
- Attempts to separate can lead to massive hemorrhage
-
Incidence varies depending on obstetric hx
- Prior cesarean section
- Prior D&E
- Multiparity
- Thought to be caused by damage to endometrial/decidual layer
-
Diagnosis
- US, confirmed by MRI antenatally
-
Different degrees
- Accrete: attaches to the myometrium
- Increta: invades the myometrium
- Percreta: penetrates through the myometrium
-
Management
- Prepare for massive transfusion
- Plan for cesarean hysterectomy

Placenta Previa
-
Placenta covers the internal cervical os
- Implants in the lower uterine segment or cervix
- 1/200 pregnancies
-
Clinical manifestations:
- Painless antepartum bleeding in 2nd and 3rd trimester
- Premature labor
- Labor or digital exam can lead to massive bleeding
- Diagnosis via US
- Requires delivery by cesarean section
- May be indication for preterm delivery if significant bleeding

Multiple Pregnancies
- Dizygotic twins: fertilization of two ova
-
Monozygotic twins: division of one fertilized ovum
- Occurs via splitting of inner cell mass of blastocyst
-
3 basic types of twin placentas:
-
Dichorionic-Diamnionic
- Each fetus has its own amniotic sac and its own chorion
- 2 placentas can be separate or fused
- May occur w/ either monozygotic or dizygotic twins and is not specific
-
Monochorionic-Diamnionic
- Each fetus has its own amniotic sac and these are covered by one common chorion
- Most common type of monozygotic twinning
- Split of fertilized egg on day 3-4
- Need to look for vascular anastomoses
-
Monochorionic-Monoamnionic
- Both fetuses in one sac
- Monozygous gestation
- Split of fertilized egg on day 7 or later
-
Dichorionic-Diamnionic

Twin-Twin Transfusion Syndrome
- Seen in monochorionic placentas
- Vascular anastamoses create abnormal sharing of fetal circulations through shunting
- Can get marked disparity in fetal blood volumes w/ possible death of one or both fetuses

Missing/Vanishing Twin
-
Acardiac twin (“Twin reversed arterial perfusion sequence or TRAPS”)
- Rare complication of monochorionic twin pregnancies
- Severe variant of twin-to-twin transfusion syndrome (TTTS)
- The “acardiac twin” is severely malformed
-
Fetus papyraceous
- Intrauterine fetal demise of a twin occurs early in pregnancy
- Retention of the fetus for min. of 10 wks
- Results in mechanical compression of the small fetus and loss of fluid ⇒ resembles parchment paper

Placental
Inflammations and Infections
-
Can see inflammation in:
- Placental cotyledons (villitis)
- Membranes (chorioamnionitis)
- Umbilical cord (funisitis/vasculitis)
-
Organisms can reach placenta by 2 pathways:
-
Ascending infection through birth canal
- Most common route
- Usually bacterial
- Can lead to premature rupture of membranes (PROM) ⇒ organisms ascend further
- See cloudy amniotic fluid and PMNs in membranes (chorioamnionitis)
- Can also see fetal response w/ PMNs in the umbilical cord (funisitis)
-
Hematogenous (transplacental) infection
- Less common
- Usually results in villitis
- May be due to infection w/ organism in the TORCH group
-
Ascending infection through birth canal

Toxemia of Pregnancy
Overview
Preeclampsia and Eclampsia
A pregnancy specific syndrome of ↓ end-organ perfusion secondary to vasospasm and endothelial activation.
Incidence in US ~ 5%
-
Preeclampsia
- HTN, proteinuria, and edema
- Usually in the 3rd trimester
- More commonly in primiparas
- Pts can develop DIC w/ lesions in the liver, kidneys, heart, placenta, and brain
- No absolute correlation b/t severity of eclampsia and magnitude of anatomic changes
-
Eclampsia
- Seizures in women w/ preeclampsia not attributable to other causes
-
HELLP Syndrome
- Hemolysis, Elevated Liver Enzymes, and Low Platelets in women w/ preeclampsia
- Seen in ~10% of women w/ severe pre-eclampsia

Preeclampsia
Pathogenesis
- Appears to begin w/ abnormal placentation that leads to placental ischemia
- Insufficient trophoblast invasion
- Decidual vasculopathy
- Possible trophoblast/cytotrophoblast abnormalities
-
↓ Uteroplacental perfusion ⇒↑ release of vasoconstrictor substances
- Vasospasm and endothelial activation ⇒ DIC, HTN, and organ damage
- Thrombosis of arterioles and capillaries ⇒ lesions in the liver, kidneys, brain, pituitary and placenta
- HTN of toxemia may be d/t defects in RAAS and prostaglandin systems

Preeclampsia
Classification
Classification dependent on the severity of signs and sx:
-
Non-Severe
- BP 140/90
-
Proteinuria
- > 300 mg in 24-hr collection or persistent 1+ on dipstick
- Asymptomatic
- Outcomes are similar to nl pregnancy
-
Severe
- BP > 160/110 on 2 occasions or while on bedrest
- Proteinuria
- ≥ 5 g in 24-hr collection or persistent 3+ on dipstick
-
Or any of the follow manifestations:
-
Renal insufficiency
- Serum creatinine > 1.1
- Oliguria < 500ml in 24 hrs
- Cerebral or visual disturbances
- Pulmonary edema or cyanosis
-
Evidence of hepatic dysfunction
- ↑ LFTs
- Epigastric or RUQ pain
- Thrombocytopenia (< 100k/μL)
-
Renal insufficiency
- ↑ risks compared to nl pregnancies

Superimposed Preeclampsia
- Chronic HTN plus new-onset proteinuria or
- Onset of CNS sx or evidence of HELLP syndrome
- Sudden ↑ in BP or proteinuria from baseline
- Complicates 25% of those w/ chronic HTN

Preeclampsia
Placental Changes
-
Histological changes:
- ↑ Villous ischemia
- Formation of prominent syncytial knots
- Thickening of trophoblastic BM
- Villous hypovascularity
- Fibrinoid necrosis and intramural lipid deposition (acute atherosis) in walls of uterine vessels
-
Gross changes:
-
Placental infarcts, occur in nl full-term placentas, are larger and more numerous
- Seen in many conditions, including pre-eclampsia
- Evolution from red to white infarcts w/ time
- Early infarct: congested, hemorrhagic villi w/ villous crowding
- Late infarct: necrosis w/ ghost villi
- ↑ Frequency of retroplacental hematomas
-
Placental infarcts, occur in nl full-term placentas, are larger and more numerous

Pre-eclampsia
Extra-Placental Findings
-
Liver:
- Irregular, focal, subcapsular, and intraparenchymal hemorrhage
- Fibrin thrombi in portal capillaries w/ foci of characteristic peripheral hemorrhagic necrosis
-
Kidney__:
- Fibrin thrombi in glomeruli and capillaries of the cortex
- ± Bilateral renal cortical necrosis
-
Brain__:
- Gross or microscopic foci of hemorrhage along w/ small-vessel thromboses
Pre-eclampsia
Clinical Manifestations
-
Pre-eclampsia
- Usually starts insidiously after 32nd week of pregnancy w/ HTN and edema
- proteinuria follows within several days
- Headaches and visual disturbances are common
- Eclampsia = CNS involvement ⇒ convulsions and eventual coma
Preeclampsia
Management
-
Non-severe preeclampsia
- Expectant management to term
- Controlled by bed rest, a balanced diet, and antihypertensive agents
-
Severe preeclampsia
- If > 34 wks ⇒ deliver
-
Expectant management to 34 wks if mother and fetus stable
- With admin of steroids ⇒ deliver
- If mother and/or fetus not stable ⇒ deliver
- Induction of delivery is the only definitive tx of established preeclampsia and eclampsia
Placental Abruption
Characteristics
Premature separation of normally implanted placenta from the uterus prior to the birth of the fetus.
- 1 in 120 births
- Pathophysiology: hemorrhage into decidua basalis
-
Clinical presentation:
-
Bleeding w/ painful uterine contractions
- Bleeding can be concealed ⇒ occurs b/t uterine decidua and placenta
- Vaginal bleeding (80-90% of cases)
- Uterine tenderness/abd pain
- Uterine hypertonus
-
Bleeding w/ painful uterine contractions
-
Management:
-
Close monitoring of mother and fetus
- Mom: VS, CBC, coags
- Fetus: HR monitoring
- May require transfusion of blood products
-
Timing of delivery
- Can wait if preterm and bleeding is limited
- If massive, delivery regardless of gestational age
-
Mode of delivery
- Can attempt vaginal delivery if bleeding is minimal
- May require cesarean section
-
Close monitoring of mother and fetus

Placental Abruption
Risk Factors
- HTN
- Maternal trauma
- Cocaine
- Cigarette use
- Previous abruption
- Sudden decompression of uterus
- Prelabor Rupture of Membranes (PROM)

Normal Villous Maturation
-
First trimester:
- Large villi w/ few vessels
-
Second trimester:
- Smaller villi w/ moderately cellular collagenized stroma
- Percentage of villi w/ inner layer of cytotrophoblast cells falls
- MΦ less numerous
- Capillaries located centrally and peripherally
-
Third trimester:
- Smaller villi due to predominance of terminal villi, w/ syncytiotrophoblastic knots in 30% of villi
- ↑ Formation of vasculosyncytial membranes

Gestational Trophoblastic Diseases (GTD)
- Group of disorders w/ proliferation of pregnancy-associated trophoblastic tissue
- Can have malignant potential
-
Types:
-
Hydatidiform mole
- Complete
- Incomplete (partial)
- Invasive Hydatidiform Mole
- Choriocarcinoma
- Placental site trophoblastic tumor
-
Hydatidiform mole

Hydatidiform Mole
Overview
Complete and Partial
Cystic swelling of chorionic villi ± trophoblastic proliferation
- 1 in 1-2k pregnancies in the US
- Much more common in the Far East
- Highest risk for women in teens or b/t age 40-50
- May precede choriocarcinoma
- Most pts present in 4th or 5th month of pregnancy
-
Clinical manifestations:
- Vaginal bleeding
- Uterus that is larger than expected for duration of pregnancy
- ↑ Serum β-HCG

Hydatidiform Mole
Pathogenesis & Genetics

Complete Hydatidiform Mole
-
All villi are affected (edematous, hydropic)
- Grape-like swellings
- See central cisterns in avascular villi
- Can see trophoblastic proliferation
- Karyotype is usually 46,XX
- No fetal parts are seen
- Small probability of development of choriocarcinoma (~2%)
Partial (Incomplete) Hydatidiform Mole
- Not all villi are affected
- Less trophoblastic proliferation
- May see fetal parts
- Karyotype is usually triploid (69, XXY)
- Lower risk of development of choriocarcinoma compared to complete mole

Complete vs Partial
Hydatidiform Mole

Hydatidiform Mole
Clinical Course
- Treated by currettage to remove tissue
-
If complete mole:
- ↑ Beta HCG for length of gestation
- After removing tissue, need to monitor pt’s level of HCG to be sure it falls to non-pregnancy level
- 2.5% chance of evolving into choriocarcinoma
- 10% chance of developing into an invasive mole
Invasive Hydatidiform Mole
- Locally destructive mole
- Can perforate uterine wall
- Hydropic villi can embolize to distant sites
- Pt experiences vaginal bleeding, uterine enlargement, ↑ beta-HCG
- Risk of uterine rupture
- Responds well to chemotherapy

Choriocarcinoma
- Rapidly invasive, widely metastasizing malignant neoplasm
- Precursor lesions can be hydatidiform moles
- Responds very well to chemotherapy
- Can invade the myometrium, penetrate blood vessels and lymphatics, and extend through uterus
-
Metastasizes to:
- Lungs (50%) and vagina (30% to 40%)
- Followed in descending order of frequency by the brain, liver, and kidney
- See ↑ beta-HCG
-
Gross:
- Soft, fleshy, yellow-white tumor w/ ischemic necrosis, cystic softening, and extensive hemorrhage
-
Microscopic:
- No villi
- Anaplastic cells, lots of mitoses
- Proliferation of cytotrophoblast and syncytiotrophoblast

Placental Site Trophoblastic Tumor (PSTT)
- Intermediate trophoblasts can remain @ residual placental implantation site (implantation site nodule) following pregnancy
- May give rise to placental site trophoblastic tumors (PSTTs)
- Rare: < 2% of gestational trophoblastic neoplasms
- Neoplastic polygonal cells infiltrate the endomyometrium
- Can follow a normal pregnancy (½), spontaneous abortion (⅙), or hydatidiform mole (⅕)
- Pts whose tumor is dx < 2 yrs after the prior pregnancy or w/ localized tumors usually do well
- Later dx or more widespread tumor implies a poor prognosis

Ectopic Pregnancy
-
Implantation of the fetus in any site other than a normal uterine location
- Fertilized ovum undergoes usual development
- Formation of placental tissue, amniotic sac, and fetus
- Host implantation site develops decidual changes
- 1/150 pregnancies
- Unusual locations can very rarely have live birth
-
Common sites:
- Within the fallopian tubes (~ 90%)
-
Ovary (Ovarian pregnancy)
- Fertilization and trapping of ovum within the follicle @ time of rupture
-
Abdominal cavity (Abdominal pregnancies)
- Fertilized ovum falls from fimbriated end of the tube
- Intrauterine portion of fallopian tube (cornual pregnancy)
-
Risk factors:
- PID w/ chronic salpingitis (35-50%)
- Peritubal adhesions due to appendicitis, endometriosis, leiomyomas, and previous surgery
- 50% of occur in nl appearing tubes
-
Clinical manifestations:
- Severe abd pain ~6 wks after LNM
- Pain d/t rupture of the fallopian tube w/ resulting pelvic hemorrhage
- Can be a life-threatening condition for the mother
